Combined effect of Neridronate and specific antibiotic therapy in a case of tuberculous spondylodiscitis

Rheumatology International

Volumn 28, Issue 5, 2008, Pages 495-498

  Quarta, L ^a   Corrado, A ^a   Melillo, N ^a   Trotta, A ^a   Scotto, G ^b   D'Onofrio, F ^a   Santoro, N ^a   Cantatore, F P ^a,c  

^a UNIVERSITY OF FOGGIA   (Italy)

^b Riuniti Hospital   (Italy)

^c Rheumatology Clinic Mario Carrozzo   (Italy)

Author keywords

Chemotherapy; Neridronate; Tuberculous spondylodiscitis

Indexed keywords

ANALGESIC AGENT; CIPROFLOXACIN; ISONIAZID; MUSCLE RELAXANT AGENT; NERIDRONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; RIFAMPICIN; TECHNETIUM 99M;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; DRUG TREATMENT FAILURE; FEMALE; HUMAN; INTERVERTEBRAL DISK DEGENERATION; LOW BACK PAIN; LUMBAR SPINE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPINE RADIOGRAPHY; TREATMENT RESPONSE; TUBERCULOUS SPONDYLODISCITIS;

ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; DISCITIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; TUBERCULOSIS, SPINAL;

EID: 43049085554     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-007-0460-0     Document Type: Article

References (14)

1. Tali ET (2004) Spinal infections. Eur J Radiol 50:120-133
2. CDC (2003) Guidelines for using the QuantiFERON®-TB test for diagnosing latent Mycobacterium tuberculosis infection. MMWR 52(No. RR-2):15-18
3. CDC (2005) Guidelines for Using the QuantiFERON®-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United State-Recommendations and Reports. MMWR 54(RR15):49-55
4. Golden MP, Vikram HR (2005) Extrapulmonary tuberculosis: an overview. Am Fam Physician 72:1761-1768
5. Grosskopf I, Ben David A, Charach G, Hochman I, Pitlik S (1994) Bone and joint tuberculosis-a 10-year review. Isr J Med Sci 30:278-283
6. Resnick D, Kransdorf MJ (2005) Osteomielitis, septic arthritis and soft tissue infection: organism. Elservier/Saunders, Amsterdam
7. Abhay N, Shekhar B (2005) Results of nonsurgical treatment of thoracic spinal tuberculosis in adults. Spine J 5:79-84
8. Gillespie SH, Billington O (1999) Activity of moxifloxacin against mycobacteria. J Antimicrob Chemother 44:395
9. Gillespie SH, Morrissey I, Everett D (2001) A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model. J Med Microbiol 50:565-570
10. Ji B, Lounis N, Truffot-Pernot C, Grosset J (1995) In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis. Antimicrob Agents Chemother 39:1341-1344
11. Kennedy N, Berger L, Curram J et al (1996) Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis. Clin Infect Dis 22:827-833
12. Khokher MA, Dandona P (1989) Bisphosphonates inhibit human osteoblast secretion and proliferation. Metabolism 38:184-187
13. Vitte C, Fleisch H, Guenther HL (1996) Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption. Endocrinology 137:2324-2333
14. Frediani B, Spreafico A, Capperucci C, Chellini F, Gambera D, Ferrata P et al (2004) Long-term effects of Neridronate on human osteoblastic cell cultures. Bone 35(4):859-869